Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LOTUS II: Oral dydrogesterone vs Crinone vaginal progesterone gel for luteal support in IVF
2012-002993-29Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dydrogesterone in female infertility and luteal insufficiency (2 arms), sponsored by Abbott Laboratories. Primary endpoint: Pregnancy rate. Started May 2015; status: completed.
02
Drugs
dydrogesterone
03
Conditions
female infertilityluteal insufficiency
Beyond the preview
Go deeper on 2012-002993-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002993-29.